Appointment of exclusive distributor of Remplir™ in Australia

7 September 2022
Posted in Company News
7 September 2022 Orthocell

Orthocell has appointed Device Technologies as the exclusive distributor of Remplir for peripheral nerve repair in Australia. 

Established since 1992, Device Technologies supplies hospitals and healthcare professionals with high calibre medical solutions. Like Orthocell, the Device team strives to enable superior health outcomes for patients, have 1000 highly-skilled staff across Australia, New Zealand and Asia and 200+ leading brands within its medical technology portfolio.

This is an exciting commercial development for Remplir  – the only Australian manufactured medical device of its kind to gain Australian regulatory approval. With 11,780 surgical repairs of peripheral nerves completed in Australian hospitals in the 2019/20 financial year, this represents a significant market opportunity.

​​ CEO of Device Technologies, Mick Trevaskis said:

“I am extremely excited to partner with Orthocell to bring their Australian Made range of peripheral nerve repair membranes to plastic and orthopaedic surgeons around Australia and New Zealand. At Device Technologies we believe in investing in innovative technologies as part of a holistic portfolio that provides value to our customers and benefits their patients. We look forward to working with the team at Orthocell to improve patient outcomes across the plastic reconstructive and orthopaedic industry.”

Click here to read today’s ASX release.